Validation of The Hong Kong Liver Cancer Staging System in Patients with Hepatocellular Carcinoma after Curative Intent Treatment

BACKGROUNDS: Recently Hong Kong Liver Cancer (HKLC) staging system has been proposed for staging of hepatocellular carcinoma (HCC), and has been shown to provide better prognostic ability than the Barcelona Clinic Liver Cancer (BCLC) system. However, the HKLC system lacks external validation, and it...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuncharunee, Alan, Siramolpiwat, Sith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373815/
https://www.ncbi.nlm.nih.gov/pubmed/28670891
http://dx.doi.org/10.22034/APJCP.2017.18.6.1697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373815/
https://www.ncbi.nlm.nih.gov/pubmed/28670891
http://dx.doi.org/10.22034/APJCP.2017.18.6.1697

Ejemplares similares